Dupont Capital Management Corp Ligand Pharmaceuticals Inc Transaction History

Dupont Capital Management Corp

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 03, 2021	SELL	$102.33 - $144.73 $363,885 - $514,659	-3,556 Closed	0 $0
Q2 2021 Jul 30, 2021	BUY	$113.03 - $155.64 $71,887 - $98,987	636 Added 21.78%	3,556 $467,000
Q1 2021 Apr 29, 2021	SELL	$99.52 - $215.83 $56,427 - $122,375	-567 Reduced 16.26%	2,920 $445,000
Q4 2020 Jan 28, 2021	BUY	$80.55 - $106.05 $29,400 - $38,708	365 Added 11.69%	3,487 $347,000
Q3 2020 Oct 29, 2020	BUY	$89.56 - $126.72 $31,883 - $45,112	356 Added 12.87%	3,122 $298,000
Q2 2020 Jul 24, 2020	BUY	$68.28 - $123.65 $136,150 - $246,558	1,994 Added 258.29%	2,766 $309,000
Q1 2020 Apr 29, 2020	BUY	$63.37 - $107.88 $48,921 - $83,283	772 New	772 $56,000
Q3 2019 Oct 28, 2019	SELL	$86.25 - $120.16 $183,885 - $256,181	-2,132 Closed	0 $0
Q2 2019 Jul 30, 2019	SELL	$107.38 - $129.34 $2.19 Million - $2.63 Million	-20,365 Reduced 90.52%	2,132 $243,000
Q1 2019 Apr 30, 2019	BUY	$105.93 - $142.47 $687,167 - $924,202	6,487 Added 40.52%	22,497 $2.83 Million
Q4 2018 Feb 01, 2019	SELL	$128.36 - $272.13 $86,001 - $182,327	-670 Reduced 4.02%	16,010 $2.17 Million
Q3 2018 Nov 05, 2018	BUY	$211.18 - $274.49 $996,980 - $1.3 Million	4,721 Added 39.48%	16,680 $4.58 Million
Q2 2018 Jul 30, 2018	BUY	$150.77 - $207.98 $318,124 - $438,837	2,110 Added 21.42%	11,959 $2.48 Million
Q1 2018 May 02, 2018	SELL	$138.63 - $182.62 $362,240 - $477,186	-2,613 Reduced 20.97%	9,849 $1.63 Million
Q3 2017 Oct 31, 2017	BUY	$120.91 - $137.94 $1.51 Million - $1.72 Million	12,462	12,462 $1.7 Million

257

18.2M

26.8K

9.3K

Ticker LGND
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 16,882,800
Market Cap $1.88B
Description
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, focuses on developing or acquiring technologies that help pharmaceutical companies to discover and develop medicines worldwide. Its commercial programs include Kyprolis and Evomela, which are used to treat multiple myeloma; Veklury for the treatment of moderate or severe COVID-19;...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.